Newsletter Volume 41, Number 3, 2026

DMPK 68に掲載予定の論文一覧

[Editorial]

Editorial

Advances in DDI evaluations: Recent trends from pre-clinical studies to regulatory submissions

Chie Emoto, R. Scott Obach

 

[Review]

Review article

Points to consider in the in vitro estimation of kinetic parameters for quantitative prediction of the drug-drug interactions caused by reversible inhibition of enzymes/transporters

Kazuya Maeda

 

Review article

Advances in In silico predictive models for DDI prediction: Implications and practical applications in drug discovery

Koichi Handa, Hideaki Mamada, Shinji Nakayama, Tadahaya Mizuno, … Yohei Kosugi

 

[Regular Articles]

Research article

N6-methyladenosine modification of MRP7 mRNA modulates its expression and paclitaxel sensitivity in lung cancer-derived A549 cells

Takuto Inamoto, Masataka Nakano, Tatsuki Fukami, Miki Nakajima

 

Research article

Regulatory impact of G-quadruplexes in the human carboxylesterase 2 gene on drug and lipid metabolism

Shintaro Kuroda, Shimon Nakashima, Seiya Takemoto, Masataka Nakano, … Tatsuki Fukami

 

Research article

Arylacetamide deacetylase deficiency potentiates ketoconazole-induced inhibition of triazolam metabolism in mice

Yuuki Otsuka, Mai Nagaoka, Miyu Watanabe, Masataka Nakano, … Tatsuki Fukami

 

[Notes]

Short communication

Glutathione-reversible inactivation of aldehyde oxidase by hydralazine contributes to inter-lot inhibition variability in human hepatocytes

Lloyd Wei Tat Tang

 

Short communication

K2-EDTA anticoagulant suppresses calcium-dependent paraoxonase 1-mediated hydrolysis in human plasma stability assays

Lloyd Wei Tat Tang


●各論文のabstractおよび論文内容詳細については,以下のリンクをご覧ください.
Drug Metabolism and Pharmacokinetics | Vol 68, June 2026 | ScienceDirect.com by Elsevier